Cite
HARVARD Citation
Belov, A. et al. (2022). Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy. American journal of hematology. 97 (6), pp. 770-779. [Online].